no clue on costs but as a chemical drug I suspect it will be significantly cheaper than the TNF and other biological drugs.
FDA may hold it up as well. It appears a meeting was cancelled but the review date held so there must be some questions. That is not unusual for a drug on the fast tract like this one is. Europe is also reviewing the drug with a decision due in the spring of next year.
Last edited by drizzit; 07/01/10 01:51 AM.
